Analyst Ratings for Immunitybio Inc (IBRX)

IBRX Rating Summary

IBRX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on IBRX
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $12.25 (+66.4%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/11/2026 BTIG
» Updated 3/24/2026
Jeet Mukherjee New Coverage Buy
(N/A)
13.00
(N/A)
8.01
(7.36)
-8.11% Details
5/20/2025 Piper Sandler
» Updated 3/4/2026
Edward Tenthoff Upgrade Overweight
(Neutral)
12.00
(7.00)
2.80
(7.36)
162.86% Details